StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) stock

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.53−0.10 (-1.16%)

Close on Nov 18, 2026Market cap $253.93MP/E –Yield –

Q32 Bio cash

Cash and short-term investments held at the end of each period.

Q32 Bio's cash was $106.27M at Jun 30, 2026. For fiscal 2025 it was $48.30M, down 38.6% from the year before. The highest annual figure on record is $262.39M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$48.30M-38.6%
FY2024Dec 31, 2024$78.61M+151.4%
FY2023Dec 31, 2023$31.26M-83.6%
FY2022Dec 31, 2022$190.58M+22.3%
FY2021Dec 31, 2021$155.87M-28.3%
FY2020Dec 31, 2020$217.43M-17.1%
FY2019Dec 31, 2019$262.39M+22.2%
FY2018Dec 31, 2018$214.74M+65.6%
FY2017Dec 31, 2017$129.66M+1038.2%
FY2016Dec 31, 2016$11.39M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$106.27M+93.8%
Q1 FY2026Mar 31, 2026$50.75M-22.5%
Q4 FY2025Dec 31, 2025$48.30M-38.6%
Q3 FY2025Sep 30, 2025$49.04M-44.9%
Q2 FY2025Jun 30, 2025$54.83M-49.1%
Q1 FY2025Mar 31, 2025$65.48M-51.6%
Q4 FY2024Dec 31, 2024$78.61M+151.4%
Q3 FY2024Sep 30, 2024$89.08M-19.3%
Q2 FY2024Jun 30, 2024$107.65M+53.1%
Q1 FY2024Mar 31, 2024$135.31M-4.7%
Q4 FY2023Dec 31, 2023$31.26M-83.6%
Q3 FY2023Sep 30, 2023$110.44M-45.1%
Q2 FY2023Jun 30, 2023$70.33M-68.8%
Q1 FY2023Mar 31, 2023$141.98M-44.6%
Q4 FY2022Dec 31, 2022$190.58M+22.3%
Q3 FY2022Sep 30, 2022$201.07M+7.2%
Q2 FY2022Jun 30, 2022$225.52M+5.7%
Q1 FY2022Mar 31, 2022$256.13M+35.8%
Q4 FY2021Dec 31, 2021$155.87M-28.3%
Q3 FY2021Sep 30, 2021$187.55M+5.4%
Q2 FY2021Jun 30, 2021$213.29M+3.2%
Q1 FY2021Mar 31, 2021$188.65M-19.7%
Q4 FY2020Dec 31, 2020$217.43M-17.1%
Q3 FY2020Sep 30, 2020$178.00M-34.0%
Q2 FY2020Jun 30, 2020$206.64M-30.1%
Q1 FY2020Mar 31, 2020$234.93M+25.0%
Q4 FY2019Dec 31, 2019$262.39M+22.2%
Q3 FY2019Sep 30, 2019$269.67M+13.5%
Q2 FY2019Jun 30, 2019$295.80M+15.8%
Q1 FY2019Mar 31, 2019$187.97M+61.0%
Q4 FY2018Dec 31, 2018$214.74M+65.6%
Q3 FY2018Sep 30, 2018$237.54M+143.0%
Q2 FY2018Jun 30, 2018$255.51M+1150.7%
Q1 FY2018Mar 31, 2018$116.73M+340.5%
Q4 FY2017Dec 31, 2017$129.66M+1038.2%
Q3 FY2017Sep 30, 2017$97.77M–
Q2 FY2017Jun 30, 2017$20.43M–
Q1 FY2017Mar 31, 2017$26.50M–
Q4 FY2016Dec 31, 2016$11.39M–

More Q32 Bio figures

See a number that looks wrong?